查看购物车
  • Traditional Chinese
  • English
  • Japanese
美国孤儿食品市场规模、份额和趋势分析报告：按给药途径、产品、应用、销售渠道和细分市场预测，2023-2030 年
市场调查报告书
商品编码
1233250

美国孤儿食品市场规模、份额和趋势分析报告：按给药途径、产品、应用、销售渠道和细分市场预测，2023-2030 年

U.S. Medical Foods For Orphan Disease Market Size, Share & Trends Analysis Report By Route Of Administration, By Product, By Application, By Sales Channel, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

美国罕见病食品市场的增长和趋势

根据Grand View Research, Inc.的最新报告，2023年至2030年美国孤儿医疗食品市场将以5.6%的复合年增长率增长，2030年将达到5亿份。预计达到 2750 万美元。

不断增长的医疗保健支出、对罕见疾病的认识、罕见疾病的流行、早期筛查等是推动市场增长的主要因素。 据美国食品和药物管理局称，苯丙酮尿症影响美国大约 15,000 人中的 1 人。 同样，根据犹他州新生儿筛查数据，美国约有 250,000 名婴儿中有 1 名患有 II 型酪氨酸血症。

在许多罕见疾病中，独特的医疗饮食对于预防严重残疾和促进儿童和成人的健康成长至关重要。 例如，枫糖浆尿症、食物蛋白引起的肠炎综合症和短肠综合症是一些常见的孤儿病，需要特殊饮食。 不含小麦、大豆、乳製品和其他过敏原的低过敏性牛奶经常被提供给患有 FPIES 的新生儿和儿童。 这些因素对于扩大规模仍然很重要。

COVID-19 大流行增加了重症患者的医疗保健服务负担和治疗敏感性。 COVID-19 检测呈阳性的患者通常免疫系统较弱，呼吸系统和其他系统受损。 例如，根据发表在 Elsevier Public Health Emergency Collection 上的一篇论文，大约一半的 COVID-19 重症患者会出现胃肠道动力不足等胃肠道问题。 此外，患者出现各种腹部问题，导致采用医疗食品。

美国罕见病食品市场整合，达能、雅培、雀巢、美赞臣和 Relief Therapeutics 占据多数份额。 这些玩家采用多种策略来增加他们的份额。 新产品开发、高研发投入以开发针对特定疾病的製剂等是参与者实施的一些策略。

美国孤儿食品市场报告要点。

  • 2022 年，按给药途径，口服部分的收入份额最高，收入份额为 70.8%。 然而，在预测期内，肠道途径预计将以最快的速度增长。
  • 到 2022 年，粉末部分将占收入份额的 35.3%，液体部分预计在预测期内也将以有利的速度增长。
  • 到 2022 年，其他业务部门占据了大部分收入份额。 然而，FPIES 部分也有望在预测期内以有利的速度增长。
  • 到 2022 年，按销售渠道划分，设施销售将占市场的大部分，达到 41.1%。 然而，在线销售部门预计在预测期内将有良好增长。

内容

第一章调查方法及范围

  • 市场细分和范围
  • 市场定义
  • 调查方法
    • 信息采购
      • 购买的数据库：
      • GVR 内部数据库
    • 初步调查：
  • 调查范围和假设
  • 报价流程
  • 列表到数据源

第 2 章执行摘要

  • 市场展望
  • 细分市场展望
  • 竞争考虑
  • 美国罕见病食品市场概况

第 3 章。美国孤儿食品市场的变量、趋势和范围

  • 描绘渗透率和增长前景
  • 价格分析
  • 用户视角分析
    • 消费者行为分析
    • 市场影响者分析
  • 技术展望
    • 技术时间表
  • 市场系列展望
    • 母公司市场展望
      • 保健品市场
    • 辅助市场展望
      • 父母营养品市场
      • 肠内餵养设备市场
  • 监管框架
    • 报销框架
      • 美国
    • 标准、合规性和安全性
  • 市场动态
    • 市场驱动因素分析
      • 个性化治疗的上升趋势
      • 需要对患者进行营养管理的罕见病患病率上升
    • 市场製约因素分析
      • 医学界缺乏认识
      • 医疗食品的高成本
    • 行业问题
      • 与小直径连接器相关的并发症
      • 与肠内营养相关的风险
  • 美国孤儿医疗食品市场分析工具
    • 美国孤儿食品市场 - 波特分析
      • 供应商议价能力：中等
      • 买方议价能力：中等
      • 新进入者的威胁：低
      • 替代威胁：低
      • 竞争对手之间的敌意：高
    • PESTEL 分析
      • 政治和法律状况
      • 经济和社会状况
      • 技术情况
  • COVID-19 对美国孤儿食品市场的影响

第 4 章美国孤儿食品市场：给药途径的估计和趋势分析

  • 美国罕见病食品市场：应用变化分析，百万美元，2022 年和 2030 年
  • 口语
  • 肠内

第 5 章美国孤儿食品市场：产品估计和趋势分析

  • 美国孤儿食品市场：产品变化分析，2022 年和 2030 年，百万美元
  • 药片
  • 粉末
  • 液体
  • 其他

第 6 章美国孤儿食品市场：应用估计和趋势分析

  • 美国罕见病食品市场：应用变化分析，2022 年和 2030 年，百万美元
  • 苯丙酮尿症
  • 嗜酸性粒细胞性食管炎
  • 复製
  • 酪氨酸血症
  • 穆苏德
  • 同型半胱氨酸尿症
  • 其他罕见病

第 7 章美国孤儿食品市场：销售渠道估计和趋势分析

  • 美国孤儿食品市场：2022 年和 2030 年销售渠道变化分析，百万美元
  • 在线销售
  • 零售销售
  • 机构销售

第8章竞争分析

  • 主要市场进入者的近期趋势和影响分析
  • 公司/竞争对手分类（主要创新者、市场领导者、初创企业）
  • 公司市场分析

第九章公司简介

  • 达能
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 雀巢
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 雅培
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 美赞臣公司
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • 救济疗法
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
Product Code: GVR-4-68040-038-6

U.S. Medical Foods For Orphan Disease Market Growth & Trends:

The U.S. medical foods for orphan disease market is expected to reach USD 527.5 million by 2030, expanding at a CAGR of 5.6% from 2023 to 2030, based on a new report by Grand View Research, Inc. Increasing healthcare expenditure, awareness about rare diseases, the prevalence of rare diseases, and early screening, are some of the key factors driving the growth of the market. As per the U.S. FDA, phenylketonuria affects about 1 in 15,000 people in the U.S. Similarly, as per the data published by UTAH's Newborn Screening, tyrosinemia type II affects approximately 1 in 250,000 babies in the U.S.

A unique medical diet is essential for a number of rare disorders in order to prevent severe impairments and promote healthy growth in children and adults. For instance, maple syrup urine disease, food protein-induced enterocolitis syndrome, and short bowel syndrome are some of the common orphan diseases that have specific dietary requirements. Hypoallergenic formulas free of wheat, soy, dairy, and other possible allergens are frequently provided to new-borns and kids with FPIES. These factors continue to be crucial for the expansion.

The COVID-19 pandemic increased the burden on healthcare services and of treatment sensitivity for critically ill patients. Patients who tested positive for COVID-19 typically suffered from weakened immunity and disruption in respiratory & other systems. For instance, according to an article published in Elsevier Public Health Emergency Collection, around half of the critically ill COVID-19 patients developed gastrointestinal problems, such as gastrointestinal hypomotility. Patients experienced various other abdominal issues, which led to increased adoption of medical foods.

The U.S. medical foods for orphan disease market is consolidated, wherein Danone, Abbott, Nestle, Mead Johnsons, and Relief Therapeutics account for the majority share. These players are adopting several strategies to increase their shares. The development of new products and high R&D investments to develop disease-specific formulas are some of the strategies players implement.

U.S. Medical Foods For Orphan Disease Market Report Highlight:

  • The oral route segment accounted for the highest revenue share in terms of route of administration in 2022 and its revenue share was 70.8%. However, the enteral route is anticipated to grow at the fastest rate over the forecast period.
  • The powder segment accounted for 35.3% of the revenue share in 2022, the liquid segment is also expected to grow at a lucrative rate over the forecast period.
  • The others segment accounted for the majority revenue share in 2022. However, FPIES segment is also expected to grow at a lucrative rate over the forecast period.
  • Institutional sales held the majority share of 41.1% the market in terms of sales channel in 2022. However, the online sales segment is expected to grow lucratively over the forecast period.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Market Definition
  • 1.3 Research Methodology
    • 1.3.1 Information Procurement
      • 1.3.1.1 Purchased Database:
      • 1.3.1.2 Gvr's Internal Database
    • 1.3.2 Primary Research:
  • 1.4 Research Scope and Assumptions
  • 1.5 Estimation Process
  • 1.6 List to Data Sources

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights
  • 2.4 U.S. Medical Foods for Orphan Disease Market Snapshot

Chapter 3 U.S. Medical Foods for Orphan Disease Market Variables, Trends & Scope

  • 3.1 Penetration and Growth Prospect Mapping
  • 3.2 Pricing Analysis
  • 3.3 User Perspective Analysis
    • 3.3.1 Consumer Behavior Analysis
    • 3.3.2 Market Influencer Analysis
  • 3.4 Technology Outlook
    • 3.4.1 Technology Timeline
  • 3.5 Market Lineage Outlook
    • 3.5.1 Parent Market Outlook
      • 3.5.1.1 Nutritional Supplements Market
    • 3.5.2 Ancillary Market Outlook
      • 3.5.2.1 Parenteral Nutrition Market
      • 3.5.2.2 Enteral Feeding Devices Market
  • 3.6 Regulatory Framework
    • 3.6.1 Reimbursement Framework
      • 3.6.1.1 U.S.
    • 3.6.2 Standards, Compliance, & Safety
  • 3.7 Market Dynamics
    • 3.7.1 Market Driver Analysis
      • 3.7.1.1 Rising Trend Of Personalized Treatment
      • 3.7.1.2 Rising Prevalence Of Orphan Diseases Requiring Nutritional Management Of Patients
    • 3.7.2 Market Restraint Analysis
      • 3.7.2.1 Lack Of Awareness Amongst The Medical Community
      • 3.7.2.1 High Cost Of Medical Foods
    • 3.7.3 Industry Challenge
      • 3.7.3.1 Complications Associated With Small-Bore Connectors
      • 3.7.3.1 Risks Associated With Enteral Feeding
  • 3.8 U.S. Medical Foods For Orphan Disease Market Analysis Tools
    • 3.8.1 U.S. Medical Foods For Orphan Disease Market - Porter's Analysis
      • 3.8.1.1 Bargaining Power Of Supplier: Moderate
      • 3.8.1.2 Bargaining Power Of Buyer: Moderate
      • 3.8.1.3 Threat Of New Entrants: Low
      • 3.8.1.4 Threat Of Substitution: Low
      • 3.8.1.5 Competitive Rivalry: High
    • 3.8.2 Pestel Analysis
      • 3.8.2.1 Political And Legal Landscape
      • 3.8.2.2 Economic And Social Landscape
      • 3.8.2.3 Technological Landscape
  • 3.9 Impact Of Covid-19 On The U.S. Medical Foods For Orphan Disease Market

Chapter 4 U.S. Medical Foods For Orphan Disease Market: Route Of Administration Estimates & Trend Analysis

  • 4.1 U.S. Medical Foods For Orphan Disease Market: Application Movement Analysis, USD Million, 2022 & 2030
  • 4.2 Oral
    • 4.2.1 Oral Market Estimates And Forecasts For Diabetic Neuropathy, 2018 - 2030 (USD Million)
  • 4.3 Enteral
    • 4.3.1 Enteral Market Estimates And Forecasts For Depression, 2018 - 2030 (USD Million)

Chapter 5 U.S. Medical Foods For Orphan Disease Market: Product Estimates & Trend Analysis

  • 5.1 U.S. Medical Foods For Orphan Disease Market: Product Movement Analysis, 2022 & 2030 USD Million
  • 5.2 Pills
    • 5.2.1 U.S. Medical Foods For Orphan Disease Market Forecasts For Pills Formulation, 2018 - 2030 (USD Million)
  • 5.3 Powder
    • 5.3.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Powder Formulation, 2018 - 2030 (USD Million)
  • 5.4 Liquid
    • 5.4.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Liquid Formulation, 2018 - 2030 (USD Million)
  • 5.5 Others
    • 5.5.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Other Formulations, 2018 - 2030 (USD Million)

Chapter 6 U.S. Medical Foods For Orphan Disease Market: Application Estimates & Trend Analysis

  • 6.1 U.S. Medical Foods For Orphan Disease Market: Application Movement Analysis, 2022 & 2030 USD Million
  • 6.2 Phenylketonuria
    • 6.2.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Phenylketonuria, 2018 - 2030 (USD Million)
  • 6.3 Eosinophilic Esophagitis
    • 6.3.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Eosinophilic Esophagitis, 2018 - 2030 (USD Million)
  • 6.4 Fpies
    • 6.4.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Fpies, 2018 - 2030 (USD Million)
  • 6.5 Tyrosinemia
    • 6.5.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Tyrosinemia, 2018 - 2030 (USD Million)
  • 6.6 Msud
    • 6.6.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Msud, 2018 - 2030 (USD Million)
  • 6.7 Homocystinuria
    • 6.7.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Homocystinuria, 2018 - 2030 (USD Million)
  • 6.8 Other Orphan Diseases
    • 6.8.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Other Orphan Disease, 2018 - 2030 (USD Million)

Chapter 7 U.S. Medical Foods For Orphan Disease Market: Sales Channel Estimates & Trend Analysis

  • 7.1 U.S. Medical Foods For Orphan Disease Market: Sales Channel Movement Analysis, 2022 & 2030 USD Million
  • 7.2 Online Sales
    • 7.2.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Online Sales Channel, 2018 - 2030 (USD Million)
  • 7.3 Retail Sales
    • 7.3.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Retail Sales Channel, 2018 - 2030 (USD Million)
  • 7.4 Institutional Sales
    • 7.4.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Institutional Sales Channel, 2018 - 2030 (USD Million)

Chapter 8 Competitive Analysis

  • 8.1 Recent Developments and Impact Analysis by Key Market Participants
  • 8.2 Company/Competition Categorization (Key Innovators, Market Leaders, and Emerging Players)
  • 8.3 Company Market Position Analysis

Chapter 9 Company Profiles

  • 9.1 DANONE
    • 9.1.1 Company overview
    • 9.1.2 Financial performance
    • 9.1.3 Product benchmarking
    • 9.1.4 Strategic initiatives
  • 9.2 NESTLE
    • 9.2.1 Company overview
    • 9.2.2 Financial performance
    • 9.2.3 Product benchmarking
    • 9.2.4 Strategic initiatives
  • 9.3 ABBOTT
    • 9.3.1 Company overview
    • 9.3.2 Financial performance
    • 9.3.3 Product benchmarking
    • 9.3.4 Strategic initiatives
  • 9.4 MEAD JOHNSON & COMPANY, LLC
    • 9.4.1 Company overview
    • 9.4.2 Financial performance
    • 9.4.3 Product benchmarking
    • 9.4.4 Strategic initiatives
  • 9.5 Relief Therapeutics
    • 9.5.1 Company overview
    • 9.5.2 Financial performance
    • 9.5.3 Product benchmarking
    • 9.5.4 Strategic initiatives

List of Tables

  • Table 1 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
  • Table 2 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 4 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 U.S. Medical Foods for Orphan Disease market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 U.S. Medical Foods for Orphan Disease market summary, 2022 (USD Million)
  • Fig. 6 U.S. Medical Foods for Orphan Disease market summary, 2022 (USD Million)
  • Fig. 7 U.S. Medical Foods for Orphan Disease market summary, 2022 (USD Million)
  • Fig. 8 U.S. Medical Foods for Orphan Disease market summary, 2022 (USD Million)
  • Fig. 9 Penetration & growth prospect mapping
  • Fig. 10 Consumer decision-making process
  • Fig. 11 Evolution of medical foods
  • Fig. 12 Parent market analysis, 2021
  • Fig. 13 Timeline for new ENFit Connectors
  • Fig. 14 Market driver analysis (Current & future impact)
  • Fig. 15 Market restraint analysis (Current & future impact)
  • Fig. 16 U.S. Medical Foods for Orphan Disease market, route of administration outlook key takeaways (USD Million)
  • Fig. 17 U.S. Medical Foods for Orphan Disease market: route of administration movement analysis (USD Million) 2022 & 2030
  • Fig. 18 Oral Disease market estimates and forecasts for diabetic neuropathy, 2018 - 2030 (USD Million)
  • Fig. 19 Enteral market estimates and forecasts for depression, 2018 - 2030 (USD Million)
  • Fig. 20 U.S. Medical foods for orphan disease market, product outlook: Key takeaways, USD Million
  • Fig. 21 U.S. Medical foods for orphan disease market: Product movement analysis, 2022 & 2030, (USD Million)
  • Fig. 22 U.S. Medical foods for orphan disease market estimates and forecasts for pills formulation, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Medical foods for orphan disease market estimates and forecasts for powder formulation, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Medical foods for orphan disease market estimates and forecasts for liquid formulation, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. Medical foods for orphan disease market estimates and forecasts for other formulations, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Medical foods for orphan disease market, application outlook: Key takeaways, USD Million
  • Fig. 27 U.S. Medical foods for orphan disease market: application movement analysis, 2022 & 2030, (USD Million)
  • Fig. 28 U.S. Medical foods for orphan disease market estimates and forecasts for phenylketonuria, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Medical foods for orphan disease market estimates and forecasts for Eosinophilic Esophagitis, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. Medical foods for orphan disease market estimates and forecasts for FPIES, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Medical foods for orphan disease market estimates and forecasts for tyrosinemia, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Medical foods for orphan disease market estimates and forecasts for MSUD, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Medical foods for orphan disease market estimates and forecasts for Homocystinuria, 2018 - 2030 (USD Million)
  • Fig. 34 U.S Medical foods for orphan disease market estimates and forecasts for other orphan disease, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Medical Foods for Orphan Disease market, sales channel outlook: Key takeaways, USD Million
  • Fig. 36 U.S. Medical Foods for Orphan Disease market: Sales channel movement analysis, 2022 & 2030, (USD Million)
  • Fig. 37 U.S. Medical foods for orphan disease market estimates and forecasts for online sales channel, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Medical foods for orphan disease market estimates and forecasts for retail sales channel, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Medical foods for orphan disease market estimates and forecasts for institutional sales channel, 2018 - 2030 (USD Million)